DK1190255T3 - Epitoper dannet ved ikke-kovalent associering af konjugater - Google Patents

Epitoper dannet ved ikke-kovalent associering af konjugater

Info

Publication number
DK1190255T3
DK1190255T3 DK00942216T DK00942216T DK1190255T3 DK 1190255 T3 DK1190255 T3 DK 1190255T3 DK 00942216 T DK00942216 T DK 00942216T DK 00942216 T DK00942216 T DK 00942216T DK 1190255 T3 DK1190255 T3 DK 1190255T3
Authority
DK
Denmark
Prior art keywords
conjugates
covalent association
ligand
epitopes formed
interacting
Prior art date
Application number
DK00942216T
Other languages
Danish (da)
English (en)
Inventor
Roger New
Istvan Toth
Original Assignee
Mozaic Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mozaic Discovery Ltd filed Critical Mozaic Discovery Ltd
Application granted granted Critical
Publication of DK1190255T3 publication Critical patent/DK1190255T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00942216T 1999-06-28 2000-06-27 Epitoper dannet ved ikke-kovalent associering af konjugater DK1190255T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9915074.0A GB9915074D0 (en) 1999-06-28 1999-06-28 Ligand-binding composition
PCT/GB2000/002465 WO2001001140A1 (en) 1999-06-28 2000-06-27 Epitopes formed by non-covalent association of conjugates

Publications (1)

Publication Number Publication Date
DK1190255T3 true DK1190255T3 (da) 2007-12-10

Family

ID=10856190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00942216T DK1190255T3 (da) 1999-06-28 2000-06-27 Epitoper dannet ved ikke-kovalent associering af konjugater

Country Status (18)

Country Link
US (2) US7413538B1 (de)
EP (2) EP1190255B1 (de)
JP (1) JP4754136B2 (de)
KR (1) KR100917285B1 (de)
CN (1) CN100354628C (de)
AT (2) ATE371190T1 (de)
AU (1) AU775310B2 (de)
BR (1) BR0012002A (de)
CA (1) CA2377783C (de)
DE (2) DE60036106T2 (de)
DK (1) DK1190255T3 (de)
ES (1) ES2292446T3 (de)
GB (1) GB9915074D0 (de)
HK (1) HK1045369A1 (de)
IL (2) IL147249A0 (de)
PT (1) PT1190255E (de)
RU (1) RU2259194C2 (de)
WO (1) WO2001001140A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504364B2 (en) 2002-03-01 2009-03-17 Receptors Llc Methods of making arrays and artificial receptors
WO2005003326A2 (en) * 2003-03-28 2005-01-13 Receptors Llc. Artificial receptors including reversibly immobilized building blocks and methods
US7469076B2 (en) 2003-09-03 2008-12-23 Receptors Llc Sensors employing combinatorial artificial receptors
US7504365B2 (en) 2004-09-03 2009-03-17 Receptors Llc Combinatorial artificial receptors including tether building blocks
WO2006029383A2 (en) 2004-09-11 2006-03-16 Receptors Llc Combinatorial artificial receptors including peptide building blocks
PT2081952E (pt) * 2006-09-20 2014-04-30 Lexcicon Ltd Péptidos
KR100840619B1 (ko) * 2006-12-19 2008-06-24 한양대학교 산학협력단 표면개질된 리포좀, 이를 포함하는 바이오칩 및 그제조방법
WO2009090650A2 (en) * 2008-01-16 2009-07-23 Ben-Gurion University Of The Negev Research And Development Authority Vaccine for alzheimer's disease
EP2391370B1 (de) 2009-02-02 2015-06-03 Galmed Research and Development Ltd. Verfahren und zusammensetzungen zur behandlung von alzheimer-krankheit
RU2500813C1 (ru) * 2012-10-15 2013-12-10 Федеральное казенное учреждение здравоохранения Ставропольский научно-исследовательский противочумный институт Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Способ получения липосомально-иммунопероксидазного конъюгата
KR101491728B1 (ko) * 2012-12-14 2015-02-11 주식회사 휴메딕스 비타민 c와 비타민 b3의 컨쥬게이트 및 그를 포함하는 항산화제

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024964A (en) 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3813821A1 (de) * 1988-04-22 1989-11-02 Hoechst Ag Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
DK0548024T3 (da) * 1991-12-19 1997-01-27 Ciba Geigy Ag Aminosulfonsyrederivater samt fremgangsmåder til deres fremstilling
WO1993022343A1 (en) * 1992-05-01 1993-11-11 The Rockfeller University Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
JP2579730B2 (ja) * 1993-01-22 1997-02-12 株式会社ディ・ディ・エス研究所 ペプチド−脂質誘導体及びリポソーム
HUT73100A (en) * 1993-07-16 1996-06-28 Harvard College Regulated apoptosis
JP3759759B2 (ja) * 1994-03-04 2006-03-29 日本油脂株式会社 リポソームおよび薬物運搬体
EP0706799B1 (de) * 1994-09-16 2001-11-14 MERCK PATENT GmbH Immunokonjugate
US6214388B1 (en) * 1994-11-09 2001-04-10 The Regents Of The University Of California Immunoliposomes that optimize internalization into target cells
US5741899A (en) * 1995-02-02 1998-04-21 Cell Genesys, Inc. Chimeric receptors comprising janus kinase for regulating cellular pro liferation
US5851536A (en) * 1995-11-22 1998-12-22 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
WO1997049425A1 (en) * 1996-06-25 1997-12-31 Stichting Instituut Voor Dierhouderij En Diergezondheid Vaccine comprising antigens bound to carriers through labile bonds
JPH10234372A (ja) * 1997-02-27 1998-09-08 Boehringer Mannheim Corp キメラ受容体を有する細胞とその作成方法、並びに その利用
US6217886B1 (en) * 1997-07-14 2001-04-17 The Board Of Trustees Of The University Of Illinois Materials and methods for making improved micelle compositions
FR2774687B1 (fr) * 1998-02-06 2002-03-22 Inst Nat Sante Rech Med Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
FR2776926B1 (fr) * 1998-04-07 2003-10-24 Inst Nat Sante Rech Med Lipopeptides inducteurs de cytotoxicite t lymphocytaire portant au moins un epitope t auxiliaire, et leurs utilisations pour la vaccination
CA2327367A1 (en) * 1998-04-07 1999-10-14 Roche Diagnostics Gmbh New compounds for dna-transfection
WO2000054807A1 (fr) * 1999-03-17 2000-09-21 Mitsubishi Chemical Corporation Complexe lie par un ligand
WO2000061114A1 (fr) * 1999-04-08 2000-10-19 Mitsubishi Chemical Corporation Particules fines ciblant des cellules, et procede de production correspondant
IL146055A0 (en) * 1999-04-23 2002-07-25 Alza Corp Conjugate having a cleavable linkage for use in a liposome
AU766570B2 (en) * 1999-04-23 2003-10-16 Mitsubishi Chemical Corporation Antibody and polyalkylene glycol-bonded liposome

Also Published As

Publication number Publication date
KR100917285B1 (ko) 2009-09-11
DE60036106T2 (de) 2008-05-15
ATE457460T1 (de) 2010-02-15
PT1190255E (pt) 2007-09-18
CN1359469A (zh) 2002-07-17
EP1190255A1 (de) 2002-03-27
JP4754136B2 (ja) 2011-08-24
AU5692300A (en) 2001-01-31
CN100354628C (zh) 2007-12-12
JP2003503424A (ja) 2003-01-28
EP1190255B1 (de) 2007-08-22
EP1722227A2 (de) 2006-11-15
EP1722227A3 (de) 2007-02-28
EP1722227B1 (de) 2010-02-10
CA2377783C (en) 2010-03-23
DE60036106D1 (de) 2007-10-04
RU2259194C2 (ru) 2005-08-27
IL147249A0 (en) 2002-08-14
US7413538B1 (en) 2008-08-19
IL147249A (en) 2007-08-19
DE60043830D1 (de) 2010-03-25
ES2292446T3 (es) 2008-03-16
WO2001001140A1 (en) 2001-01-04
ATE371190T1 (de) 2007-09-15
US20080152703A1 (en) 2008-06-26
BR0012002A (pt) 2002-03-12
CA2377783A1 (en) 2001-01-04
GB9915074D0 (en) 1999-08-25
HK1045369A1 (en) 2002-11-22
KR20020042537A (ko) 2002-06-05
AU775310B2 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
DK1190255T3 (da) Epitoper dannet ved ikke-kovalent associering af konjugater
PT1459751E (pt) (s,s)-reboxetina para tratar as enxaquecas
FR2763244B1 (fr) Composition vaccinale multivalente a porteur mixte
AR033395A1 (es) Un articulo endurecido, un metodo para formar un articulo endurecido y un articulo producido por el metodo.
ATE397458T1 (de) Neue heilmittel für krebs
DK1674111T3 (da) Anti-glyypican-3-antistof
FI915697A (fi) N,o-sulfaterade heparosaner, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaollande dem.
NL173734C (nl) Voertuig met verplaatsbaar werkplatform, zogenaamde hoogwerker.
AU3210301A (en) Retractable roof
IT8921837A0 (it) Composizione di combustibile ad elevato contenuto energetico, contenete quadriciclano.
DE60101185D1 (de) Verlängerbarer Tisch mit einer Tischplatte, die aus miteinander verbundenen Streifen besteht
DE50107971D1 (de) Scherenhubtisch
AR023979A1 (es) Procesos para preparar compuestos intermedios de plaguicidas
ATE534319T1 (de) Klappgestänge
BR8003680A (pt) Maquina textil de ponto por urdume, especialmente maquina de emalhar tipo raschel
FR2798049B1 (fr) Siege obtenu par pliage de materiau
IT1250879B (it) Gruppo ottico per veicoli.
ES2186457A1 (es) Sistema mecanico de desplazamiento de elementos moviles perfeccionado.
ES2101812T3 (es) Maquina circular multi alimentada para tejer punto.
ES1055801U (es) Alineador de envases sin presion.
IT1228671B (it) Compasso, particolarmente per disegnatori.
ES1045857Y (es) Estructura plegable multiuso, perfeccionada
FR2820496B1 (fr) Engin guide perfectionne, notamment missile
IT242380Y1 (it) Cassa di cartone ondulato formata da due pezzi all'occorrenzafacilmente separabili, col pezzo inferiore che ha funzione di
ES234311U (es) Amarre rectangular regulable para reses estabuladas.